Colon Cancer Clinical Trials

A listing of Colon Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

 

Arizona

Chandler Arizona

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Gilbert Arizona

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Mesa Arizona

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Scottsdale Arizona

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Arkansas

Fayetteville Arkansas 72703

A Phase 2 clinical study for patients with Untreated Metastatic Colorectal Cancer

California

Anaheim California

A Phase 3 clinical study for patients with Colon Cancer or Colorectal Carcinoma

Anaheim California

A Phase 3 clinical study for patients with Colon Cancer or Colorectal Carcinoma

Long Beach California 90806

Patients are needed to participate in a clinical research study for the treatment of Colon Cancer

Los Angeles California

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Pasadena California

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

View More ▼

Santa Barbara California

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Santa Monica California 90404

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

Stanford California 94305

A clinical research study of CT perfusion

Colorado

Aurora Colorado

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Aurora Colorado 80045

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

Colorado Springs Colorado

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Denver Colorado

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Connecticut

New Haven Connecticut 06519

A Phase 1/Phase 2 clinical study for patients using Combination of Varlilumab and Nivolumab

Norwalk Connecticut 06856

A Phase 2 clinical study for patients with Untreated Metastatic Colorectal Cancer

Delaware

Newark Delaware 19713

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

District of Columbia

Washington District of Columbia 20006

A clinical trial seeking patients for a research study for the treatment of Colorectal Neoplasms or Colorectal Cancer

Washington District of Columbia 20007

A Phase 1/Phase 2 clinical study for patients using Combination of Varlilumab and Nivolumab

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study for the treatment of Colon Cancer

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study of Regorafenib to evaluate Colon Cancer

Florida

Additional Locations Florida

Patients are needed to participate in a clinical research study of Regorafenib to evaluate Colorectal Neoplasms, Adenocarcinoma of the Colon or Adenocarcinoma of the Rectum

Altamonte Springs Florida

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Debary Florida 32713

A Phase 2 clinical study for patients with Untreated Metastatic Colorectal Cancer

Miami Florida

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Ocala Florida

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

View More ▼

Orlando Florida

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Tampa Florida

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Georgia

Memorial University Medical Center
Savannah Georgia 31404

CALGB 80702: A Phase III trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.

Illinois

Sherman Health
Elgin Illinois 60123

NSABP P-5 Phase III Randomized Study of Adjuvant Rosuvastatin in Patients With Resected Stage I or II Colon Cancer

View More ▼

Niles Illinois

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Indiana

Goshen Indiana 46526

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

Lafayette Indiana

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Iowa

Ames Iowa

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Louisiana

New Orleans Louisiana

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Maryland

Baltimore Maryland

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Baltimore Maryland 21205

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Chevy Chase Maryland 20815

A clinical trial seeking patients for a research study for the treatment of Colorectal Neoplasms or Colorectal Cancer

Massachusetts

Boston Massachusetts 02114

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Boston Massachusetts 02215

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Missouri

Jefferson City Missouri

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

St. Louis Missouri

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Nebraska

Lincoln Nebraska

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Omaha Nebraska

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Nevada

Henderson Nevada

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

Las Vegas Nevada

A clinical research study of Ruxolitinib, Regorafenib and Placebo for the treatment of Metastatic Colorectal Cancer

New York

The Rockefeller University Hospital
New York New York 10065

Identification of autoantibodies targeting genes implicated in metastatic cancer